Benitec Biopharma, Inc. (BNTC)
8.98
-0.60
(-6.26%)
USD |
NASDAQ |
Oct 02, 16:00
8.95
-0.03
(-0.33%)
After-Hours: 20:00
Benitec Biopharma EPS Diluted (Quarterly) : -0.3722 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3722 |
| March 31, 2026 | -0.2417 |
| December 31, 2025 | -0.2575 |
| September 30, 2025 | -0.2159 |
| June 30, 2025 | -0.2139 |
| March 31, 2025 | -0.3757 |
| December 31, 2024 | -0.2564 |
| September 30, 2024 | -0.4753 |
| June 30, 2024 | -0.5293 |
| March 31, 2024 | -1.636 |
| December 31, 2023 | -2.639 |
| September 30, 2023 | -2.760 |
| June 30, 2023 | -2.832 |
| March 31, 2023 | -2.671 |
| December 31, 2022 | -3.337 |
| September 30, 2022 | -7.976 |
| June 30, 2022 | -10.54 |
| March 31, 2022 | -6.813 |
| December 31, 2021 | -10.03 |
| September 30, 2021 | -10.50 |
| June 30, 2021 | -8.328 |
| March 31, 2021 | -14.00 |
| December 31, 2020 | -12.86 |
| September 30, 2020 | -41.69 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | -50.05 |
| December 31, 2019 | -51.08 |
| September 30, 2019 | -340.58 |
| June 30, 2019 | -437.22 |
| March 31, 2019 | -507.16 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.7591 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -3.022 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.81M |
| Total Expenses (Quarterly) | 12.81M |
| Enterprise Value | 129.74M |
| Earnings Yield | -12.11% |
| Normalized Earnings Yield | -12.11 |